Patients suffering from remitting relapsing MS express a reduced level of PD-L1 on their peripheral blood mononuclear cells (PBMCs) compared to the control, but significantly elevated levels compared to an acute MS exacerbation, linking an increase in PD-L1 levels to remission. The gene discussed is CD274; the disease is myeloid sarcoma.